Please assess the completion status of the following clinical trial:

Trial Title: CRESTOR Athero Imaging Head to Head IVUS Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical indication for coronary angiography~* Angiographic evidence of Coronary Artery Disease (CAD), as defined by at least 1 lesion in a native coronary artery that has \>20% reduction in lumen diameter by visual estimation~* Left main coronary artery must have \<=50% reduction in lumen diameter by visual estimation~* LDL-C \>100 mg/dL (2.6 mmol/L) for patients with no statin therapy in the past 4 weeks; LDL-C \>80mg/dL (2.08mmol/L) for patients on therapy in the past 4 weeks~Exclusion Criteria:~* Use of certain lipid-lowering medication for more than 3 months within the previous 12 months. Longer periods of treatment are not permitted because of the potential effects of such therapy on coronary atherosclerosis.~* Patients who have symptoms consistent with moderate or greater severity of Congestive Heart Failure (CHF).~* Clinically significant heart disease which, in the opinion of the Principal Investigator (or designee), is likely to require coronary bypass surgery, cardiac transplantation, surgical repair and/or replacement during the course of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Rosuvastatin 20 mg (Type: EXPERIMENTAL): Rosuvastatin 20 mg distributed in 2-week run-in period
- Atorvastatin 40 mg (Type: ACTIVE_COMPARATOR): Atorvastatin 40 mg distributed in 2-week run-in period
- Rosuvastatin 40 mg (Type: EXPERIMENTAL): Rosuvastatin 40 mg distributed in core 2-year study
- Atorvastatin 80 mg (Type: ACTIVE_COMPARATOR): Atorvastatin 80 mg distributed in core 2-year study

Based on this trial design, predict the completion outcome and termination type (if applicable).